dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 21. aprill 2020
Viit
1.4-4/1376-1
Registreeritud
21. aprill 2020
Dokumendi liik
Sissetulev kiri
Adressaat
Eesti Vabariigi Alaline Esindus EL juures
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-4 Kutsed ja kirjavahetus rahvusvahelistel seminaridel, konverentsidel jt üritustel osalemiseks
Toimik
1.4-4/2020
Vastutaja
Liisa Lents (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
22. aprill 2020

Failid

  • 📎Copy of Attendance list meeting 180118.pdf420 KB
  • 📎E-kiri.pdf89 KB
  • 📎Invitation Bio agents TPC on Update annex III to Directive 2000_54_EC_safe2414435.pdf182 KB
  • 📎List of nominations_TPC_2019.pdf321 KB
  • 📎Updating Directive 2000-54 with SARS-CoV-2.pdf370 KB
  • 📎v1_Draft agenda_Expert group meeting_BA Directive and COVID-19.pdf226 KB

Sisu (failidest)

Ref. Ares(2020)2139171 - 20/04/2020 Updating the Biological Agents Directive 2000/54/EC in the context of the current COVID- 19 pandemic The EU Occupational Safety and Health (OSH) Directives set up minimum requirements at EU level for the protection of workers against risks to which they are or can be exposed to at work. The Framework Directive 89/391/EEC sets out the main principles of prevention and protection of occupational risks for all sectors of activity. These provisions are further developed by a set of individual Directives, among which, the Biological Agents Directive 2000/54/EC ('Directive 2000/54/EC') which lays down detailed preventive and protective measures aimed at the protection of workers against risks to their health and safety arising or likely to arise from exposure to biological agents at work. Annex III to Directive 2000/54/EC provides a list of biological agents known to infect humans, and sets out their classification and characteristics, which determine the type of protective measures to be put in place. In October 2019, Commission Directive 2019/1833 amended Annex III (amongst others) in order to reflect the latest technological and scientific developments in the field1. For example, a large number of biological agents were added to the annex, including the Severe Acute Respiratory Syndrome-related coronavirus (SARS-virus) and the Middle East Respiratory Syndrome coronavirus (MERS-virus), which have both been classified as group 3 biological agents. Other coronaviruses that are known to be pathogenic are currently classified as group 2 biological agents. The field of infectious diseases is a constantly evolving and the identification and classification of biological agents is an ongoing activity. With the outbreak of the new coronavirus disease, COVID-19, early epidemiological and clinical investigations are now ongoing to identify and understand the severity of the new virus, which has been called “severe acute respiratory syndrome coronavirus 2” or, in short, “SARS-CoV-2”2. Because of its great similarity with the SARS-virus and MERS-virus, as well as the data and knowledge currently available concerning the virus’ transmission patterns, clinical features and risk factors for infection, the current lack of a vaccine and therapy, and the large distribution possibility in the population, several EU Member States have provisionally classified SARS-CoV-2 to risk group 3. As risk classifications are thus being introduced at national level, the Commission services is considering to organise an expert group meeting with Member State scientific experts to consider if a further technical update of Directive 2000/54/EC is possible and relevant, and thus to include a new entry in Annex III of SARS-CoV-2 with its respective classification and characteristics. This technical update would follow the Comitology procedure. Note: Until SARS-CoV-2 has been included in Annex III to Directive 2000/54/EC, the provisions of the Framework Directive 89/391/EEC and 2000/54/EC, as well as other EU OSH relevant individual Directives, are fully applicable to the exposure of workers to biological agents. This means that workers exposed to COVID-19 are fully covered by the general and specific OSH obligations, in particular the obligation for employers to assess the risks and put in place the appropriate preventive and protective measures, including notifications to the competent authority of workers exposed or the provision of adequate personal protective equipment. 1 Commission Directive 2019/1833 was adopted in accordance with the comitology procedure provided for in Article 17 of Directive 89/391/EEC (regulatory procedure with scrutiny). 2 See: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus- disease-(covid-2019)-and-the-virus-that-causes-it Ref. Ares(2020)2139171 - 20/04/2020 E02662 - Expert Group on Directive 200054EC - Biological Agents January 18th 2018 Directive 200054EEC Biological Agent (Luxembourg)- ATTENDANCE LIST # lastName firstName organisation countryscheduledSessions signature Federal Ministry of Labour, Social Affairs and Consumer 1 KERNMAYER Andrea AT Y Protection 2 DE RIDDER Maurits Federal Public Service Employment, Labour and Social Dialogue BE Y 3 KRISTO Dijana RPUE HR Y 4 KOKKOFITIS CHRISTOS Department of Labour Inspection CY N 5 SKJOLDAGER Charlotte The Danish Working Environment Authority DK Y 6 RAIK Ivar RPUE EE N 7 Haidak Maarika ESTONIA - MINISTRY OF SOCIAL AFFAIRES (GOV) EE Y 8 SAUNI Riitta Ministry of Social Affairs and Health FI Y 9 LASSUS Matthieu DIRECTION GENERALE du TRAVAIL FR N 10 JÄCKEL Udo BAUA DE Y 11 KUDÁSZ Ferenc OMFI HU Y 12 NOTLEY sheena HSA IE Y 13 Arkins Darren Health and Safety Authority IE ? 14 AHMAD abdul ghani Ministero del Lavoro e delle Politiche Sociali IT N 15 PERA Alessandra LAVORO IT N 16 KONDROTIENE VILIJA Ministry of Social Security and Labour LT Y 17 KOEGEL Armin Division of health at work LU Y 18 BARTH Bruno ITM LU Y 19 Kortbeek Titia RIVM NL ? 20 VOORDOUW Bettie rivm NL Y 21 ZABŁOCKI Bartosz Ministry of Health of the Republic of Poland PL Y SKOMOROWSK 22 Monika MZ PL ? A 23 ANDRÉ Emília Telo RPUE PT Y 24 COJOCARU Livia counsellor, Ministry of Labour and Social Justice RO Y 25 CERVICESCU CATALIN Inspectiamuncii RO ? 26 KALLAYOVA Daniela Ministry of Health of the Slovak Republic SK N 27 KUDELA Tomas Ministry of Health of the Slovak Republic SK ? 28 BECHIBANI Petra Ministry of labour, family and Social Affairs SI Y 29 TRATNIK Etbin GOVERNMENT SI N HERNÁNDEZ 30 ANA insht ES N CALLEJA MARIA 31 MIRON INSSBT ES Y ASUNCION 32 ESKILS Katarina Swedish Work Environment Authority SE Y 33 WELLENS Alison hse GB ? 34 Brown David UK - HSE (GOV) GB Y 35 VIT Michael National Institute of Public Health CZ Y 36 WOOLMER Terence UK - Engineering Employers Federation (EEF) - (E) GB Y 37 MUSU Tony B - ETUI BE Y 38 KOJIMA Kazunobu WHO CH 39 40 Saatja: Tiiu Noobel <[email protected]> Saadetud: 21.04.2020 10:39 Adressaat: SM Info <[email protected]>; Annely Salumaa <[email protected]>; Thea Treier Brüsselis <[email protected]> Teema: Kiri nr 10.2-11/348 / FW: Ares(2020)2139171 - Technical update of Annex III to Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work Manused: Updating Directive 2000-54 with SARS-CoV-2.pdf; List of nominations_TPC_2019.pdf; v1_Draft agenda_Expert group meeting_BA Directive and COVID-19.pdf; Invitation Bio agents TPC on Update annex III to Directive 2000_54_EC_safe2414435.pdf; Copy of Attendance list meeting 180118.pdf Tere Edastan Komisjoni kirja (EV AEEL registreerimisnumber 10.2-11/348, 21.04.2020). Palutakse nimetada/kinnitada esindajad 27.04.2020 ja 11.05.2020 toimuvatele kohtumistele. Vastamise tähtaeg on juba homme 22.04.2020 keskpäeval. Heade soovidega Tiiu Noobel Sekretär Eesti alaline esindus Euroopa Liidu juures Rue Guimard 11/13, 1040 Brüssel Tel: + 32 2227 4337, [email protected] https://eu.mfa.ee/et/ -----Original Message----- From: Esindus EL juures üldaadress <[email protected]> Sent: Tuesday, April 21, 2020 8:48 AM To: Tiiu Noobel <[email protected]> Subject: FW: Ares(2020)2139171 - Technical update of Annex III to Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work -----Original Message----- From: ve_empl.b.3(EMPL) <[email protected]> Sent: Monday, April 20, 2020 6:40 PM To: (Embassy of Spain = Ambassade d'Espagne) <[email protected]>; (Liechtenstein Representation in Brussels) <[email protected]>; (Mission of Switzerland to the EU = Mission de la Suisse auprès de l'UE) <[email protected]>; (Norway mission to EU) <[email protected]>; (Permanent Representation of Belgium = Représentation permanente de la Belgique) <[email protected]>; (Permanent Representation of Bulgaria = Représentation permanente de la Bulgarie) <[email protected]>; (Permanent Representation of Cyprus to the EU) <[email protected]>; (Permanent Representation of Denmark = Représentation permanente du Danemark) <[email protected]>; (Permanent Representation of Finland = Représentation permanente de la Finlande) <[email protected]>; (Permanent Representation of Greece = Représentation permanente de la Grèce) <[email protected]>; (Permanent Representation of Ireland = Représentation permanente de l'Irlande) <[email protected]>; (Permanent Representation of Luxembourg = Représentation permanente du Luxembourg) <[email protected]>; (Permanent Representation of Malta = Représentation permanente de Malte) <[email protected]>; (Permanent Representation of Poland = Représentation permanente de la Pologne) <[email protected]>; (Permanent Representation of the Czech Republic = Représentation permanente de la République tchèque) <[email protected]>; ANDRASSY Irena (Permanent Representation of Croatia = Représentation permanente de la Croatie) <[email protected]>; BRITO Nuno (Permanent Representation of Portugal = Représentation permanente du Portugal) <[email protected]>; CLAUSS Michael (Permanent Representation of Germany = Représentation permanente de l'Allemagne) <[email protected]>; DANIELSSON Lars (Permanent Representation of Sweden = Représentation permanente de Suède) <[email protected]>; DE GROOT Robert (Permanent Representation of the Netherlands to the European Union) <[email protected]>; JAVORCIK Peter (Permanent Representation Slovakia to the EU) <[email protected]>; LÉGLISE-COSTA Philippe (Permanent Representation of France = Représentation permanente de la France) <[email protected]>; MARSCHIK Nikolaus (Permanent Representation of Austria = Représentation permanente de l'Autriche) <[email protected]>; NELIUPŠIENĖ Jovita (Permanent Representation of Lithuania = Représentation permanente de la Lituanie) <[email protected]>; ODOBESCU Luminiţa Teodora (Permanent Representation of Romania = Représentation permanente de la Roumanie) <[email protected]>; PAVLUTA-DESLANDES Sanita (Permanent Representation of Latvia = Représentation permanente de la Lettonie) <[email protected]>; PÁLSSON Gunnar (Icelandic Mission to the European Union) <[email protected]>; [email protected]; [email protected] (Permanent Representation of Slovenia = Représentation permanente de la Slovénie) <[email protected]>; STELBACZKY Tibor (Permanent Representation of Hungary = Représentation permanente de la Hongrie) <[email protected]>; Esindus EL juures üldaadress <[email protected]> Subject: Ares(2020)2139171 - Technical update of Annex III to Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work Please find attached document Ares(2020)2139171 from KORTE Joost (EMPL) dated 20/04/2020. Veuillez trouver ci-joint le document Ares(2020)2139171 de KORTE Joost (EMPL) daté du 20/04/2020. Ref. Ares(2020)2139171 - 20/04/2020 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR EMPLOYMENT, SOCIAL AFFAIRS AND INCLUSION The Director-General Brussels EMPL.B.3/AJ/sc/ (2020)2414435 Subject: Technical update of Annex III to Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work Dear Ambassador, With the outbreak of the new coronavirus disease (COVID-19), caused by SARS-CoV-2 virus, the European Commission is preparing a technical update of Annex III to Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC). In accordance with article 19 of Directive 2000/54/EC, and as established in Article 17 of Directive 89/391/EEC on the introduction of measures to encourage improvements in the safety and health of workers at work, the Commission shall be assisted by a committee (“Technical Progress Committee”) to make purely technical adjustments to the Annexes of Directive 2000/54/EC. These non-essentials measures might be adopted on imperative grounds of urgency under the urgency procedure pursuant to Article 5a of Decision 1999/468 laying down the procedures for the exercise of implementing powers conferred on the Commission (as amended). Firstly, the Commission services would like to organize a virtual expert group meeting with Member State scientific experts to discuss a further technical update of Directive 2000/54/EC – i.e. a new entry in Annex III of SARS-CoV-2 with its respective classification and characteristics. The meeting would take place on 27 April 2020 via videoconference / webinar. Therefore, I would kindly request the national authorities to confirm the nominations of scientific experts (as enclosed to this letter) previously appointed to support work on the last technical update which lead to the adoption of Commission Directive (EU) 2019/1833 of 24 October 2019 amending Annexes I, III, V and VI to Directive 2000/54/EC, or, if needed, to appoint a different expert. Secondly, with a view of convening the Technical Progress Committee, I would kindly request the national authorities to confirm their respective nominations to the Technical Progress Committee where the draft Commission Directive amending Annex III to Directive 2000/54/EC will be discussed and submitted to vote, or, if needed, to appoint a different delegate. The delegate shall have a specific mandate to present the position of Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111 the Member State and to participate in the process of voting. The meeting would take place on 11 May 2020 via videoconference/webinar. Please note that for your convenience a list of nominations for the previous meeting of Technical Progress Committee held on 11 June 2019 is enclosed to this letter. Please note that representatives of third parties (for example EFTA States) shall not be present at and shall not participate in voting of the Technical Progress Committee. Please note that both virtual meetings will be held in English (without interpretation). The final date and final background documents/draft measures will be sent directly to the nominated expert/delegate. We kindly request you to send the confirmation at your earliest convenience and not later than 22 April 2020 at noon to our Secretariat ([email protected]), with a copy to [email protected]. Yours sincerely, Joost KORTE Enclosures: List of nominations – scientific experts List of nominations – TPC Draft agenda Background document for the expert group meeting 2 Electronically signed on 20/04/2020 18:24 (UTC+02) in accordance with article 4.2 (Validity of electronic documents) of Commission Decision 2004/563 Ref. Ares(2020)2139171 - 20/04/2020 Technical Update of Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) List of nominations Technical Progress Committee Meeting, 11 June 2019 Country Mr/Ms First name Last name Organisation/Address Bundesministerium für Arbeit, Soziales, Austria Ms Andrea KERNMAYER Gesundheit und Konsumentenschutz Sektion VII, Gruppe A, Zentral-Arbeitsinspektorat Belgium Mr Karel VAN DAMME Head of section in the Department of Epidemiology of Bulgaria Mr (Dr.) Galin EMILOV KAMENOV the National Centre of Infectious and Parasitic Diseases Croatia Ms Katarina ZAHARIEV-VUKŠINIĆ Cyprus Mr Themistoclis KYRIACOU Labour Inspection Officer Czech Republic Ms Markéta HOLUBOVÁ Ministry of Health Denmark Ms Susanne HØYER M. Science, Chemistry Adviser Working Life Development Department Estonia Ms Maarika HAIDAK Ministry of Social Affairs of Estonia Address: Suur-Ameerika 1, 10122 Tallinn Senior Ministerial Adviser, Health/Medical Affairs Ministry of Social Affairs and Health Finland Ms Ritta SAUNI Department for Work and Gender Equality Uimalankatu 1, Tampere P.O. Box 33, FI-00023 Government, Finland 1 Technical Update of Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) France Mr Jérémy DE SAINT-JORES Bundesanstalt für Arbeitsschutz und Arbeitsmedizin Mr (Dr.) Frank DIETERICH Nöldnerstraße 40 10317 Berlin Germany Bundesministerium für Arbeit und Soziales Mr (Dr.) Philipp BAYER Villemombler Str. 76 53123 Bonn Labour Inspector – H&S / Designated Rapporteur – Public Official Greece Mr Ilias TYLIGADAS Ministry of Labour, Social Security and Social Solidarity 29, Stadiou Str. Athens GREECE National Public Health Institute Hungary Mr Ferenc KUDÁSZ 1096 Budapest, Nagyvárad tér 2. Ireland Ms Sheena NOTLEY The Health Safety and Authority of Ireland DEPARTMENT OF OCCUPATIONAL Italy Ms Diana GAGLIARDI AND ENVIRONMENTAL MEDICINE, EPIDEMIOLOGY AND HYGIENE Senior expert of the Labour Relations and Labour Latvia Ms Jolanta GEDUŠA Protection Policy Department Ministry of Welfare Advisor of Working Environment Division Lithuania Ms Vilija KONDROTIENE Ministry of Social Security and Labour A.Vivulskio st. 13, LT-03610 Vilnius Responsible du Service Affaires internationales Luxembourg Ms Patrice FURLANI 3, rue des Primeurs, L-2362 Strassen 2 Technical Update of Directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC) Membre du Service Affaires internationales Mr Bruno BARTH 3, rue des Primeurs, L-2362 Strassen Principal OHS Officer Malta Ms Catriona FRANCICA Occupational Health and Safety Authority 17, Triq Edgar Ferro, Tal-Pieta, PTA 1533 Netherlands Ms Bettie VOORDOUW RIVM Head of the Laboratory of Biohazards of the Poland Mr Rafał GÓRNY Central Institute for Labour Protection – National Research Institute Portugal Ms Emília TELO Autoridade para as Condições do Trabalho Adviser within the Ministry of Labour and Social Romania Ms Camelia IORGULESCU Justice Regional Hygienist, Regional Authority of Public Health Slovakia Ms Eleonora FABIANOVA Cesta k nemocnici 1 SK 975 56 - Banska Bystrica Slovak Republic Ministry of Labor, Family, Social Affairs Slovenia Ms Petra BECHIBANI and Equal Opportunities INSTITUTO NACIONAL DE SEGURIDAD, SALUD Y Spain Ms (Dª) Asunción MIRÓN HERNÁNDEZ BIENESTAR EN EL TRABAJO Ms Helen KARLBERG Sweden Arbetsmiljöverket Mr Jens ÅHMAN 112 79 Stockholm 3 Ref. Ares(2020)2139171 - 20/04/2020 EUROPEAN COMMISSION Employment, Social Affairs and Inclusion DG Employment 1ST MEETING OF THE EXPERT GROUP ON INFORMATION AND CONSULTATION OF WORKERS – EMPLOYEE INVOLVEMENT DEDICATED TO UPDATING DIRECTIVE 2000/54/EC (BIOLOGICAL AGENTS) IN THE CONTEXT OF THE COVID-19 PANDEMIC LUXEMBOURG, 27APRIL 2020 VIDEOCONFERENCE/WEBINAR STARTING AT 10:00 AM DRAFT AGENDA 1. ADOPTION OF THE DRAFT AGENDA 2. INFORMATION FROM DG EMPL:  Context  Procedural aspects 3. TOUR DE TABLE AND DISCUSSION 4. IDENTIFICATION OF TECHNICAL POINTS FOR POSSIBLE UPDATE 5. CLOSING OF MEETING AND NEXT STEPS 6. AOB
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel